Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Which Patients Benefit?

被引：29
|
作者：
Niegisch, Guenter [1 ]
Lorch, Anja [2 ]
Droller, Michael J. [3 ]
Lavery, Hugh J. [3 ]
Stensland, Kristian D. [3 ]
Albers, Peter [1 ]
机构：
[1] Univ Dusseldorf, Dept Urol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Dept Urol, Div Med Urooncol, D-40225 Dusseldorf, Germany
[3] Mt Sinai Med Ctr, Dept Urol, New York, NY 10029 USA
来源：
EUROPEAN UROLOGY | 2013年 / 64卷 / 03期
关键词：
RADICAL CYSTECTOMY; UROTHELIAL CARCINOMA; CISPLATIN; METHOTREXATE; VINBLASTINE; GEMCITABINE; TOMOGRAPHY; SERIES; TRIAL;
D O I：
10.1016/j.eururo.2013.06.002
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：355 / 357
页数：3
相关论文
共 50 条
  • [1] COST EFFECTIVENESS ANALYSIS OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Stevenson, Scott
    Deibert, Chris
    McKiernan, James
    JOURNAL OF UROLOGY, 2013, 189 (04): : E170 - E170
  • [2] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
  • [3] NEOADJUVANT CHEMOTHERAPY RESULTS IN SKELETAL MUSCLE INDEX DECLINE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Steinsiek, Nikki
    Acevedo, Ann Martinez
    Guimaraes, Alexander
    Achim, Virginie
    Jones, Paul
    Bash, Jasper
    Whitaker, Makena
    Amling, Christopher L.
    Cetnar, Jeremy
    Liu, Jen-Jane
    JOURNAL OF UROLOGY, 2018, 199 (04): : E531 - E531
  • [4] Cost-effectiveness analysis of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
    Stevenson, Scott M.
    Deibert, Chris M.
    McKiernan, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [5] ETIOLOGY OF TREATMENT DELAYS IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    El-Arabi, Ahmad
    Sherman, Garth
    Holzbeierlein, Jeffrey
    Lee, Eugene
    Wulff-Burchfield, Elizabeth
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1025 - E1026
  • [6] Etiology of Treatment Delays in Patients Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    El-Arabi, Ahmad M.
    Alam, Syed M.
    Sherman, Garth
    Parker, William P.
    Thompson, Jeffrey
    Holzbeierlein, Jeffrey M.
    Lee, Eugene K.
    Wulff-Burchfield, Elizabeth M.
    BLADDER CANCER, 2020, 6 (04) : 435 - 444
  • [7] Safety of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and malignant ureteric obstruction
    Strother, Marshall C.
    Kutikov, Alexander
    Epstein, Matthew
    Bochner, Emily
    Deng, Mengying
    Handorf, Elizabeth
    Lewis, Bianca
    Ghatalia, Pooja
    Greenberg, Richard E.
    Chen, David
    Viterbo, Rosalia
    Anari, Fern
    Smaldone, Marc C.
    Zibelman, Matthew R.
    Uzzo, Robert G.
    Plimack, Elizabeth R.
    Geynisman, Daniel M.
    BJU INTERNATIONAL, 2022, 129 (03) : 364 - 372
  • [8] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [9] Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours
    Sengelov, L
    von der Maase, H
    Lundbeck, F
    Barlebo, H
    Colstrup, H
    Engelholm, SA
    Krarup, T
    Madsen, EL
    Meyhoff, HH
    Mommsen, S
    Nielsen, OS
    Pedersen, D
    Steven, K
    Sorensen, B
    ACTA ONCOLOGICA, 2002, 41 (05) : 447 - 456
  • [10] Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy
    Lotan, Yair
    de Jong, Joep J.
    Liu, Vinnie Y. T.
    Bismar, Tarek A.
    Boorjian, Stephen A.
    Huang, Huei-Chung
    Davicioni, Elai
    Mian, Omar Y.
    Wright, Jonathan L.
    Necchi, Andrea
    Dall'Era, Marc A.
    Kaimakliotis, Hristos Z.
    Black, Peter C.
    Gibb, Ewan A.
    Boormans, Joost L.
    JOURNAL OF UROLOGY, 2022, 207 (03): : 541 - 550
12345